Package 75834-122-01

{"route": ["ORAL"], "spl_id": "d14fe0b4-4772-45ee-b0d9-6ea50e5c9733", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0375834122014", "0375834123011"], "unii": ["X4HES1O11F"], "rxcui": ["197311", "197313"], "spl_set_id": ["7e83897b-9662-4f69-860e-da357800fc55"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Nivagen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (75834-122-01)", "package_ndc": "75834-122-01", "marketing_start_date": "20161015"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (75834-122-05)", "package_ndc": "75834-122-05", "marketing_start_date": "20161015"}], "brand_name": "Acyclovir", "product_id": "75834-122_d14fe0b4-4772-45ee-b0d9-6ea50e5c9733", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "75834-122", "generic_name": "Acyclovir", "labeler_name": "Nivagen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA202168", "marketing_category": "ANDA", "marketing_start_date": "20161015", "listing_expiration_date": "20261231"}